Video Experimental Relacionado
Updated: Apr 30, 2026
07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.5K
La aparición y la progresión de la dermatitis atópica y la inmunoterapia alérgica: un estudio de cohorte
Oliver Pfaar1, Hartmut Richter2, Thomas Müller3
1Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, Philipps-Universität Marburg, University Hospital Marburg, Marburg, Germany.
The World Allergy Organization journal
|August 27, 2025
Resumen
La inmunoterapia con alérgenos (AIT) reduce significativamente la necesidad de medicación para la dermatitis atópica (DA) y reduce el riesgo de desarrollar DA. Este estudio de la evidencia del mundo real confirma AIT
Área de la Ciencia:
- Inmunología
- Dermatología
- Estudios de pruebas en el mundo real
Sus antecedentes:
- La inmunoterapia alérgica (AIT) es la única terapia modificadora de la enfermedad para las enfermedades alérgicas.
- Los estudios controlados tienen limitaciones; la evidencia del mundo real (RWE) ofrece información complementaria.
- Es crucial investigar el impacto de la AIT en la progresión y aparición de la dermatitis atópica (DA).
Objetivo del estudio:
- Evaluar el efecto terapéutico de la AIT en la progresión y aparición de la dermatitis atópica (DA).
- Para analizar grandes datos de prescripción longitudinal de varios tipos de AIT en un entorno del mundo real.
Principales métodos:
- Análisis de los datos de prescripción de IQVIATM LRx para 122.600 pacientes asegurados legalmente en Alemania (2008-2017).
- Incluir las prescripciones de AIT para los ácaros del polvo doméstico (HDM), las hierbas (GR) y los árboles de floración temprana (EFT).
- Comparación de los grupos AIT con los grupos de control que recibieron medicamentos para la rinitis alérgica sintomática (RA).
Principales resultados:
- Las tres formas de AIT disminuyeron significativamente la necesidad de medicación para la EA en comparación con los controles.
- La AIT redujo significativamente la probabilidad de desarrollar EA en pacientes sin EA preexistente.
- Este efecto se observó en comparación con los pacientes alérgicos que no recibieron AIT.
Conclusiones:
- La evidencia del mundo real confirma los efectos positivos de la AIT en el manejo y la prevención de la EA.
- Los estudios de RWE proporcionan datos complementarios valiosos para los ensayos clínicos de AIT.
- Los hallazgos apoyan el papel de AIT como modificador de la enfermedad, mejorando la eficacia del tratamiento futuro.
Videos de Conceptos Relacionados
02:06Allergic Reactions
26.4K
Overview
26.4K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
01:26Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
01:28Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
01:13Asthma III: Clinical Manifestations
49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49